Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Systemic Lupus Erythematosus (With and Without Nephritis)”

15 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 15 of 15 results

Testing effectiveness (Phase 2)Study completedNCT03393013
What this trial is testing

KZR-616 in Patients With SLE With and Without Lupus Nephritis

Who this might be right for
Lupus NephritisSystemic Lupus Erythematosus
Kezar Life Sciences, Inc. 69
Large-scale testing (Phase 3)WithdrawnNCT02074020
What this trial is testing

CHABLIS-SC2: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus With or Without Nephritis

Who this might be right for
Systemic Lupus Erythematosus
Anthera Pharmaceuticals
Early research (Phase 1)Study completedNCT00818948
What this trial is testing

Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis

Who this might be right for
NephritisSystemic Lupus Erythematosus
Amgen 56
Large-scale testing (Phase 3)Looking for participantsNCT06711887
What this trial is testing

Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension)

Who this might be right for
Lupus Nephritis
Novartis Pharmaceuticals 348
Large-scale testing (Phase 3)Ended earlyNCT02514967
What this trial is testing

CHABLIS7.5: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus With or Without Nephritis

Who this might be right for
Systemic Lupus Erythematosus
Anthera Pharmaceuticals 3
Testing effectiveness (Phase 2)Looking for participantsNCT07523542
What this trial is testing

SELECT-SLE: Biomarker-Guided CAR-T Target Selection for Refractory Lupus

Who this might be right for
REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUSLupus Nephritis
Beijing Biotech 24
Testing effectiveness (Phase 2)Looking for participantsNCT05268289
What this trial is testing

Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V

Who this might be right for
Lupus Nephritis
Novartis Pharmaceuticals 240
Early research (Phase 1)Looking for participantsNCT07085104
What this trial is testing

Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

Who this might be right for
Systemic Lupus Erythematosus (With and Without Nephritis)Idiopathic Inflammatory MyopathySystemic Sclerosis
Allogene Therapeutics 66
Testing effectiveness (Phase 2)Looking for participantsNCT06350110
What this trial is testing

Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus ErythematosusLupus NephritisAutoimmune Diseases+6 more
Essen Biotech 75
Testing effectiveness (Phase 2)Looking for participantsNCT07328581
What this trial is testing

A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis

Who this might be right for
Systemic Lupus Erythematosus (SLE)Lupus Nephritis (LN)
iCell Gene Therapeutics 20
Early research (Phase 1)Ended earlyNCT01369628
What this trial is testing

Atacicept in Lupus Nephritis Patients Taking Stable Regimen of Mycophenolate Mofetil

Who this might be right for
Lupus Nephritis
EMD Serono 1
Testing effectiveness (Phase 2)Looking for participantsNCT07598396
What this trial is testing

Evaluate Mosunetuzumab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis

Who this might be right for
LupusSystemic Lupus ErythematosusLupus Nephritis
Hoffmann-La Roche 30
Early research (Phase 1)Study completedNCT04128579
What this trial is testing

Study of EQ001 (Itolizumab) in Systemic Lupus Erythematosus With or Without Active Proliferative Nephritis

Who this might be right for
Lupus ErythematosusLupus Nephritis
Biocon Limited 52
Early research (Phase 1)Active Not RecruitingNCT06544330
What this trial is testing

SYNCAR-001 + STK-009 Without Conditioning Chemotherapy (Lymphodepletion) in Subjects With Severe, Refractory Systemic Autoimmune Rheumatic Disease

Who this might be right for
Systemic Lupus ErythematosusLupus NephritisSystemic Sclerosis
Synthekine 48
Early research (Phase 1)Looking for participantsNCT07629583
What this trial is testing

To Evaluate the Effects of Cevostamab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis

Who this might be right for
Lupus Erythematosus, Systemic
Genentech, Inc. 46